Table 1.

Clinicopathologic characteristics of patients included in RPPA analysis of NSCLC tumors

Specimen numberHistologyAge at surgery, yGenderRaceSmoking statusT stageN stageM stageOverall stage
700SQ79MCaucasianFormerT2N1M0IIB
708SQ61FAfrican AmericanNeverT2N1M0IIB
719SQ76MCaucasianFormerT2N0M0IB
720SQ67FCaucasianCurrentT1N1M0IIA
739AD76FCaucasianFormerT2N2M1IV
746AD67FCaucasianFormerT4N0M0IIIB
759AD60MCaucasianCurrentT2N2M0IIIB
763AD60FCaucasianCurrentT2N2M0IIIA
764AD67FCaucasianCurrentT2N0M0IB
767AD53FAfrican AmericanCurrentT1N2M0IIIA
771SQ67MCaucasianFormerT2N1M0IIB
773AD77FCaucasianFormerT4N2M1IV
774SQ67MAfrican AmericanFormerT4N2M0IIIB
781SQ80FCaucasianFormerT1N0M0IA
782AD67MCaucasianFormerT4N0M0IIIB
786SQ81MCaucasianFormerT2N1M0IIB
795AD64MCaucasianNeverT1N0M0IA
799SQ61FCaucasianCurrentT2N0M0IB
801AD63FCaucasianCurrentT2N1M0IIB
803AD65FAfrican AmericanCurrentT2N1M0IIB
804SQ77MCaucasianFormerT2N0M0IB
811SQ62MCaucasianCurrentT2N1M0IIB
813SQ70MCaucasianCurrentT4N0M0IIIB
816AD73MCaucasianFormerT2N0M0IB
833AD72MCaucasianCurrentT1N0M0IA
844SQ67MCaucasianFormerT2N1M0IB
847AD60FCaucasianCurrentT2N0M0IB
848AD48FCaucasianCurrentT2N0M0IB
849AD57MCaucasianCurrentT1N1M0IIA
852SQ67MCaucasianCurrentT2N0M0IB
857SQ71MCaucasianCurrentT2N0M0IB
870SQ53MCaucasianCurrentT2N1M0IIB
877AD68MCaucasianFormerT2N1M0IIB
879SQ67MCaucasianCurrentT2N1M0IIB
883AD58FCaucasianFormerT2N1M0IIB
884AD70FCaucasianFormerT1N0M0IA
890AD68MCaucasianFormerT2N0M0IB
896AD49FCaucasianCurrentT1N0M0IA
899AD65FCaucasianCurrentT1N0M0IA
905SQ80MCaucasianFormerT2N1M0IIB
910AD74FCaucasianFormerT2N0M0IB
911SQ65FCaucasianFormerT2N0M0IB
913SQ61MCaucasianFormerT2N2M0IIIA
920AD54FCaucasianCurrentT2N0M0IB
930SQ66MCaucasianFormerT2N1M0IIB
931SQ71FCaucasianCurrentT4N0M0IIIB

Abbrevations: AD, adenocarcinoma; SQ, squamous cell carcinoma.